Brief: OpGen Announces Successful Completion Of Clinical Trial Enrollment For Unyvero Urinary Tract Infection Panel
03/10/2022 12:41
Oct 3 (Reuters) - OpGen Inc OPGN.O :
* OPGEN ANNOUNCES SUCCESSFUL COMPLETION OF CLINICAL TRIAL
ENROLLMENT FOR UNYVERO URINARY TRACT INFECTION PANEL
Source text for Eikon: ID:nGNXbF20W2
Further company coverage: OPGN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CapForce
See all newsBrief: Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing